Subintimal vs. Intraplaque Coronary Rechanneling. Do Results Vary?

Coronary rechanneling is difficult by nature, and there are several techniques for it aimed at improving technical success. Some of these strategies entail the subintimal crossing of the occluded segment, while others entail intraplaque crossing, without leaving the true lumen. However, there is scarce or no information on the results of both strategies.

Researchers analyzed 75 consecutive patients undergoing angiography and optical coherence tomography (OCT) after rechanneling, who were included in the ISAR-OCT-CTO (Intracoronary Stenting and Angiographic Results – Optical Coherence Tomography for Chronic Total Occlusions) registry. The study endpoints were stenosis diameter, lumen loss, and rate of uncovered or malapposed struts.

Intraplaque rechanneling was used in 46 patients, while dissection and re-entry techniques were used in 29 patients.


Read also: Prosthesis Mismatch in Supra and Intra Annular valves.


There were no significant differences in terms of in-segment stenosis diameter (mean 36.9% vs. 31.2%; p = 0.656), in-stent late lumen loss (0.21 mm vs. 0.23 mm; p = 0.83), or in-segment late lumen loss (0.03 vs. 0.13; p = 0.39) between intraplaque vs. subintimal techniques.

The OCT imaging analysis showed comparable strut coverage (79.9% vs. 71.3%; p = 0.255) but much higher malapposition rates among patients in the subintimal technique group (6.6% vs. 13.6%; p < 0.001).

The use of dissection and re-entry techniques only predicted higher rates of strut malapposition.

Conclusion

Intraplaque and subintimal rechanneling techniques are associated with comparable mid-term angiographic results. Although the rate of uncovered struts is high after any rechanneling, it does not vary according to the technique used.

The only difference observed is a higher chance of strut malapposition with dissection and re-entry techniques.

Original title: Subintimal Versus Intraplaque Recanalization of Coronary Chronic Total Occlusions. Mid-Term Angiographic and OCT Findings From the ISAR-OCT-CTO Registry.

Reference: Erion Xhepa et al. J Am Coll Cardiol Intv 2019, Article in press.



Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | FLAVOUR II: Angiography-Derived FFR-Guided vs. IVUS-Guided PCI

Physiological assessment is effective when it comes to decision-making for percutaneous coronary intervention (PCI). However, despite the available evidence, its use remains limited. AngioFFR...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...